Dexcom Inc Q2 2023 Earnings Call Summary - Thomson StreetEvents

Dexcom Inc Q2 2023 Earnings Call Summary

Dexcom Inc Q2 2023 Earnings Call Summary - Thomson StreetEvents
Dexcom Inc Q2 2023 Earnings Call Summary
Published Jul 27, 2023
16 pages (9615 words) — Published Jul 27, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of DXCM.OQ earnings conference call or presentation 27-Jul-23 8:30pm GMT

  
Brief Excerpt:

...Company reported gross profit of $553.5 million, Adjusted EBITDA of $232.6 million, cash and cash equivalents of $3.6 billion....

  
Report Type:

Brief

Source:
Company:
DexCom Inc
Ticker
DXCM.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Danielle Joy Antalffy - UBS Investment Bank, Research Division - Analyst : Sorry about that. I didn't realize I was lowering my hand, so apologies for that. Guys, you saw a really nice revenue acceleration across the business this quarter. The (inaudible) OUS number really does stand out. It looks like one of your stronger growth quarters internationally in a while. Can you provide a little bit more color on the sources of that international strength as you think about the key regions that you've entered and extending both the G7 and the DexCom ONE launches across these different geographies?


Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Great. Congrats on a really nice quarter. Looks like you guys raised guidance for basically 2x the size of the beat in the quarter. So I'd love to just hear where the confidence is coming from? How to think about U.S. and OUS growth in third and fourth quarter as we progress and where that upside in guidance is coming from? And any color as it relates to Type 2 basal within that guidance range?


Question: Mathew Justin Blackman - Stifel, Nicolaus & Company, Incorporated, Research Division - Analyst : I wanted to ask on the PCP channel. Were you encountering any friction points in those offices above and beyond what you may have expected with basal? And I guess, conversely, is there anything you anticipated would be challenging that may be playing out less challenging. And also, I'm curious, is your PCP sales force finding a meaningful number of type 1s in that channel?

Table Of Contents

Dexcom Inc Q3 2023 Earnings Call Summary – 2023-10-26 – US$ 54.00 – Edited Brief of DXCM.OQ earnings conference call or presentation 26-Oct-23 8:30pm GMT

Dexcom Inc at Robert W Baird Global Healthcare Conference Summary – 2023-09-13 – US$ 54.00 – Edited Brief of DXCM.OQ presentation 13-Sep-23 1:40pm GMT

Dexcom Inc at Robert W Baird Global Healthcare Conference Transcript – 2023-09-13 – US$ 54.00 – Edited Transcript of DXCM.OQ presentation 13-Sep-23 1:40pm GMT

Dexcom Inc at Wells Fargo Healthcare Conference Transcript – 2023-09-06 – US$ 54.00 – Edited Transcript of DXCM.OQ presentation 6-Sep-23 7:45pm GMT

Dexcom Inc Q2 2023 Earnings Call Transcript – 2023-07-27 – US$ 54.00 – Edited Transcript of DXCM.OQ earnings conference call or presentation 27-Jul-23 8:30pm GMT

Dexcom Inc Investor Day Summary – 2023-06-23 – US$ 54.00 – Edited Brief of DXCM.OQ corporate analyst meeting</ 23-Jun-23 9:30pm GMT

Dexcom Inc Investor Day Transcript – 2023-06-23 – US$ 54.00 – Edited Transcript of DXCM.OQ corporate analyst meeting</ 23-Jun-23 9:30pm GMT

Dexcom Inc at William Blair Growth Stock Conference Summary – 2023-06-07 – US$ 54.00 – Edited Brief of DXCM.OQ presentation 7-Jun-23 5:40pm GMT

Dexcom Inc at William Blair Growth Stock Conference Transcript – 2023-06-07 – US$ 54.00 – Edited Transcript of DXCM.OQ presentation 7-Jun-23 5:40pm GMT

Dexcom Inc Q1 2023 Earnings Call Summary – 2023-04-27 – US$ 54.00 – Edited Brief of DXCM.OQ earnings conference call or presentation 27-Apr-23 8:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Dexcom Inc Q2 2023 Earnings Call Summary" Jul 27, 2023. Alacra Store. May 13, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Dexcom-Inc-Earnings-Call-B15653981>
  
APA:
Thomson StreetEvents. (2023). Dexcom Inc Q2 2023 Earnings Call Summary Jul 27, 2023. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2023-Dexcom-Inc-Earnings-Call-B15653981>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.